Chien-Yu Cheng - JoVE Visualize

Showing results (11-20 of 85) with videos related to

Pageof 9

Sort By:

Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|September 11, 2016

Tenofovir disoproxil fumarate-associated hypophosphatemia as determined by fractional excretion of filtered phosphate in HIV-infected patientsChien-Yu Cheng, Shu-Yin Chang, Mei-Hui Lin, et al.

BMJ (Clinical Research Ed.)|July 10, 2019

Quadruple versus triple combination antiretroviral therapies for treatment naive people with HIV: systematic review and meta-analysis of randomised controlled trialsQi Feng, Aoshuang Zhou, Huachun Zou, et al.

Journal of the Formosan Medical Association = Taiwan Yi Zhi|December 23, 2022

Correlation of adverse effects and antibody responses following homologous and heterologous COVID19 prime-boost vaccinationsAristine Cheng, Ming-Ju Hsieh, Sui-Yuan Chang, et al.

Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|February 14, 2021

Clinical validation of an automated reverse transcription-insulated isothermal PCR assay for the detection of severe acute respiratory syndrome coronavirus 2Pai-Ling Chang, Chia-Yi Lin, Cheng-Pin Chen, et al.

BMC Infectious Diseases|February 26, 2014

Effectiveness of tigecycline-based versus colistin- based therapy for treatment of pneumonia caused by multidrug-resistant Acinetobacter baumannii in a critical setting: a matched cohort analysisYu-Chung Chuang, Chien-Yu Cheng, Wang-Huei Sheng, et al.

Journal of the International AIDS Society|November 14, 2014

Safety of rilpivirine plus nucleoside reverse-transcriptase inhibitors in HIV-infected Taiwanese with a higher prevalence of hepatitis virus infectionPei-Ying Wu, Chien-Yu Cheng, Yu-Zhen Luo, et al.

Plos One|November 20, 2024

Assessment of risk factors for virological nonsuppression following switch to dolutegravir and lamivudine, or bictegravir, emtricitabine, and tenofovir alafenamide fumarate in a real-world cohort of treatment-experienced adults living with HIVShu-Yuan Lee, Yi-Chun Lin, Cheng-Pin Chen, et al.

Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|August 19, 2019

Dual therapy with ritonavir-boosted protease inhibitor (PI) plus lamivudine versus triple therapy with ritonavir-boosted PI plus two nucleos(t)ide reverse-transcriptase inhibitor in HIV-infected patients with viral suppressionTung-Che Hung, Guan-Jhou Chen, Shu-Hsing Cheng, et al.

Journal of Infection in Developing Countries|September 9, 2020

Characteristics of HIV-positive pregnant women and HIV- and antiretroviral therapy-exposed fetuses: A case-control studyTung-Che Hung, Li-Cheng Lu, Mei-Hui Lin, et al.

Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|April 26, 2020

Lopinavir/ritonavir did not shorten the duration of SARS CoV-2 shedding in patients with mild pneumonia in TaiwanChien-Yu Cheng, Yu-Lin Lee, Cheng-Pin Chen, et al.

Pageof 9

Showing results (11-20 of 85) with videos related to

Sort By:

Pageof 9

Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|September 11, 2016

Tenofovir disoproxil fumarate-associated hypophosphatemia as determined by fractional excretion of filtered phosphate in HIV-infected patientsChien-Yu Cheng, Shu-Yin Chang, Mei-Hui Lin, et al.

BMJ (Clinical Research Ed.)|July 10, 2019

Quadruple versus triple combination antiretroviral therapies for treatment naive people with HIV: systematic review and meta-analysis of randomised controlled trialsQi Feng, Aoshuang Zhou, Huachun Zou, et al.

Journal of the Formosan Medical Association = Taiwan Yi Zhi|December 23, 2022

Correlation of adverse effects and antibody responses following homologous and heterologous COVID19 prime-boost vaccinationsAristine Cheng, Ming-Ju Hsieh, Sui-Yuan Chang, et al.

Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|February 14, 2021

Clinical validation of an automated reverse transcription-insulated isothermal PCR assay for the detection of severe acute respiratory syndrome coronavirus 2Pai-Ling Chang, Chia-Yi Lin, Cheng-Pin Chen, et al.

BMC Infectious Diseases|February 26, 2014

Effectiveness of tigecycline-based versus colistin- based therapy for treatment of pneumonia caused by multidrug-resistant Acinetobacter baumannii in a critical setting: a matched cohort analysisYu-Chung Chuang, Chien-Yu Cheng, Wang-Huei Sheng, et al.

Journal of the International AIDS Society|November 14, 2014

Safety of rilpivirine plus nucleoside reverse-transcriptase inhibitors in HIV-infected Taiwanese with a higher prevalence of hepatitis virus infectionPei-Ying Wu, Chien-Yu Cheng, Yu-Zhen Luo, et al.

Plos One|November 20, 2024

Assessment of risk factors for virological nonsuppression following switch to dolutegravir and lamivudine, or bictegravir, emtricitabine, and tenofovir alafenamide fumarate in a real-world cohort of treatment-experienced adults living with HIVShu-Yuan Lee, Yi-Chun Lin, Cheng-Pin Chen, et al.

Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|August 19, 2019

Dual therapy with ritonavir-boosted protease inhibitor (PI) plus lamivudine versus triple therapy with ritonavir-boosted PI plus two nucleos(t)ide reverse-transcriptase inhibitor in HIV-infected patients with viral suppressionTung-Che Hung, Guan-Jhou Chen, Shu-Hsing Cheng, et al.

Journal of Infection in Developing Countries|September 9, 2020

Characteristics of HIV-positive pregnant women and HIV- and antiretroviral therapy-exposed fetuses: A case-control studyTung-Che Hung, Li-Cheng Lu, Mei-Hui Lin, et al.

Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|April 26, 2020

Lopinavir/ritonavir did not shorten the duration of SARS CoV-2 shedding in patients with mild pneumonia in TaiwanChien-Yu Cheng, Yu-Lin Lee, Cheng-Pin Chen, et al.

Pageof 9